GPT and metabolic dysfunction-associated steatotic liver disease: The key novel findings of this study are: first, that plasma TRAIL levels are significantly reduced in patients with the severe form of NAFLD (i.e. NASH), negatively associating with plasma ALT, even after adjustment for diabetes, BMI, age and sex.